Ozaita Mintegui, Andrés,Busquets García, Arnau,Maldonado López, Rafael
申请号：
HRP20200324
公开号：
HRP20200324T1
申请日:
2020.02.26
申请国别(地区):
HR
年份:
2020
代理人:
摘要：
The invention relates to antagonists of the cannabinoid receptor CBI for use in the treatment and prevention of diseases associated with neural dendritic abnormalities, such as Down's syndrome, Angelman's syndrome, Rett syndrome and tuberous sclerosis. More specifically, the invention provides a method of treatment or prevention of such diseases by the administration of the compound rimonabant.
